Search Results 21 – 40 of 61
Laboratory Testing
Management of People With HIV and Antiretroviral Therapy Experience
Optimizing Antiretroviral Therapy in the Setting of Virologic Suppression
Cost Considerations and Antiretroviral Therapy
Poor CD4 Cell Recovery and Persistent Inflammation Despite Viral Suppression
Hepatitis C Virus/HIV Coinfection
Drug-Drug Interactions
Drug-Drug Interactions: Protease Inhibitors and Other Drugs
Drug-Resistance Testing
Introduction
HLA-B* 5701 Screening
Drug-Drug Interactions: Integrase Strand Transfer Inhibitors and Other Drugs
Discontinuation or Interruption of Antiretroviral Therapy
Drug-Drug Interactions: Nucleoside Reverse Transcriptase Inhibitors and Other Drugs
Tests for Initial Assessment and Monitoring of People With HIV
Special Populations
Special Populations: Substance Use Disorders and HIV
Plasma HIV-1 RNA (Viral Load) and CD4 Count Monitoring
Special Populations: HIV-2 Infection
Virologic Failure